171 related articles for article (PubMed ID: 4157335)
1. Activity of tetracycline, doxycycline, and minocycline against methicillin-susceptible and -resistant staphylococci.
Minuth JN; Holmes TM; Musher DM
Antimicrob Agents Chemother; 1974 Oct; 6(4):411-4. PubMed ID: 4157335
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of minocycline susceptibility of methicillin-resistant Staphylococcus pseudintermedius.
Weese JS; Sweetman K; Edson H; Rousseau J
Vet Microbiol; 2013 Mar; 162(2-4):968-971. PubMed ID: 23107659
[TBL] [Abstract][Full Text] [Related]
3. Correlation of in vitro resistance of Staphylococcus aureus to tetracycline, doxycycline, and minocycline with in vivo use.
Lewis SA; Altemeier WA
Chemotherapy; 1976; 22(5):319-23. PubMed ID: 947710
[TBL] [Abstract][Full Text] [Related]
4. Comparative susceptibility of anaerobic bacteria to minocycline, doxycycline, and tetracycline.
Chow AW; Patten V; Guze LB
Antimicrob Agents Chemother; 1975 Jan; 7(1):46-9. PubMed ID: 1137358
[TBL] [Abstract][Full Text] [Related]
5. [Comparative activity of tetracycline, doxycycline and minocycline against Haemophilus].
Dabernat H; Delmas C; Bauriaud R; Lareng MB
Pathol Biol (Paris); 1983 May; 31(5):413-8. PubMed ID: 6353333
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs.
Hnot ML; Cole LK; Lorch G; Papich MG; Rajala-Schultz PJ; Daniels JB
Vet Dermatol; 2015 Oct; 26(5):334-8, e70-1. PubMed ID: 26216025
[TBL] [Abstract][Full Text] [Related]
7. Letter: Effect of minocycline on tetracycline-resistant Staphylococcus aureus.
Leigh DA; Simmons K
Lancet; 1974 May; 1(7864):1006. PubMed ID: 4133636
[No Abstract] [Full Text] [Related]
8. Expression of resistance to tetracyclines in strains of methicillin-resistant Staphylococcus aureus.
Trzcinski K; Cooper BS; Hryniewicz W; Dowson CG
J Antimicrob Chemother; 2000 Jun; 45(6):763-70. PubMed ID: 10837427
[TBL] [Abstract][Full Text] [Related]
9. Susceptibilities of Mycoplasma hominis, Mycoplasma pneumoniae, and Ureaplasma urealyticum to new glycylcyclines in comparison with those to older tetracyclines.
Kenny GE; Cartwright FD
Antimicrob Agents Chemother; 1994 Nov; 38(11):2628-32. PubMed ID: 7872759
[TBL] [Abstract][Full Text] [Related]
10. Differences in susceptibility of Enterobacteriaceae and penicillin-resistant Staphylococcus aureus to tetracycline and minocycline.
Candanoza C; Ellner PD
Antimicrob Agents Chemother; 1975 Mar; 7(3):227-8. PubMed ID: 1040464
[TBL] [Abstract][Full Text] [Related]
11. [Activity in vitro and pharmacokinetics of minocycline (author's transl)].
Simon C; Malerczyk V; Preuss I; Schmidt K; Grahmann H
Arzneimittelforschung; 1976 Apr; 26(4):556-60. PubMed ID: 782466
[TBL] [Abstract][Full Text] [Related]
12. N,N-dimethylglycyl-amido derivative of minocycline and 6-demethyl-6-desoxytetracycline, two new glycylcyclines highly effective against tetracycline-resistant gram-positive cocci.
Goldstein FW; Kitzis MD; Acar JF
Antimicrob Agents Chemother; 1994 Sep; 38(9):2218-20. PubMed ID: 7811053
[TBL] [Abstract][Full Text] [Related]
13. Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300.
Schwartz BS; Graber CJ; Diep BA; Basuino L; Perdreau-Remington F; Chambers HF
Clin Infect Dis; 2009 May; 48(10):1483-4. PubMed ID: 19374563
[No Abstract] [Full Text] [Related]
14. Comparison of the in vitro activity of the glycylcycline tigecycline (formerly GAR-936) with those of tetracycline, minocycline, and doxycycline against isolates of nontuberculous mycobacteria.
Wallace RJ; Brown-Elliott BA; Crist CJ; Mann L; Wilson RW
Antimicrob Agents Chemother; 2002 Oct; 46(10):3164-7. PubMed ID: 12234839
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
Maaland MG; Papich MG; Turnidge J; Guardabassi L
J Clin Microbiol; 2013 Nov; 51(11):3547-54. PubMed ID: 23966509
[TBL] [Abstract][Full Text] [Related]
16. Sensitivity of staphylococcus aureus to minocycline, doxycycline and tetracycline.
Klastersky J; Daneau D
Int J Clin Pharmacol; 1972 Nov; 6(4):324-7. PubMed ID: 4641847
[No Abstract] [Full Text] [Related]
17. Aerobic and anaerobic susceptibility tests with three tetracyclines. Reassessment of the "class concept" of disk testing.
Barry AL; Draper DL; Wong MK
Am J Clin Pathol; 1978 Nov; 70(5):821-5. PubMed ID: 717289
[TBL] [Abstract][Full Text] [Related]
18. Tetracycline-resistant propionibacteria from acne patients are cross-resistant to doxycycline, but sensitive to minocycline.
Eady EA; Jones CE; Gardner KJ; Taylor JP; Cove JH; Cunliffe WJ
Br J Dermatol; 1993 May; 128(5):556-60. PubMed ID: 8504049
[TBL] [Abstract][Full Text] [Related]
19. The genetics of tetracycline resistance in Staphylococcus aureus.
Asheshov EH
J Gen Microbiol; 1975 May; 88(1):132-40. PubMed ID: 1151329
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo antibacterial activities of the glycylcyclines, a new class of semisynthetic tetracyclines.
Testa RT; Petersen PJ; Jacobus NV; Sum PE; Lee VJ; Tally FP
Antimicrob Agents Chemother; 1993 Nov; 37(11):2270-7. PubMed ID: 8285606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
